Pharmaceutical Executive July 5, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.
PE: The FDA first gave clearance to Femaseed last September. For our audience, can you briefly explain how this technology works, and any enhancements that you see being made to it as time goes on?
Lee-Sepsick: Femaseed was purposely designed to enhance the normal transport of sperm that’s required in order for conception to occur. We place sperm directly into the fallopian tube that is the site of fertilization. Our technology purposely positions balloon technology at the opening of the tube, so it’s a much safer way to deliver it to...
Today's Sponsors
Today's Sponsor